Table 1 Clinico-pathologic parameters of patients involved in the study
| Â | Â | n (%) |
|---|---|---|
Age(years) |  | 55.76 ± 9.17 |
EFGR IHC Score |  | 15.39 ± 41.52 |
Menopausal Status | Pre Menopausal | 17 (19.1) |
Post Menopausal | 72 (80.9) | |
Histological Type | endometroid | 77 (86.5) |
serous | 7 (7.9) | |
clear cell | 1 (1.1) | |
carcinosarcoma | 4 (4.5) | |
Grade | Grade I | 35 (39.3) |
Grade II | 38 (42.7) | |
Grade III | 16 (18) | |
Myometial Invasion | Limited To Endometrium | 6 (6.7) |
Less Than Half Of Myometrium | 31 (34.8) | |
More Than Half Of Myometrium | 52 (58.4) | |
Cervical Invasion | Present | 23 (25.8) |
Absent | 66 (74.2) | |
Adnexal Involvement | Present | 9 (10.1) |
Absent | 80 (89.9) | |
Nodal Status | N0 | 84 (94.4) |
N1 | 4 (4.5) | |
N2 | 1 (1.1) | |
Lymphovascular Invasion | Present | 6 (6.7) |
Absent | 83 (93.3) | |
T Stage | T1 | 62 (69.7) |
T2 | 16 (18) | |
T3 | 8 (9) | |
T4 | 3 (3.4) | |
FIGO Stage | Stage IA | 34 (38.2) |
Stage IB | 27 (30.3) | |
Stage II | 17 (19.1) | |
Stage IIIA | 7 (7.9) | |
Stage IIIB | 1 (1.1) | |
Stage IV | 3 (3.4) |